标题
How Many Diseases Are Colorectal Cancer?
作者
关键词
-
出版物
Gastroenterology Research and Practice
Volume 2012, Issue -, Pages 1-12
出版商
Hindawi Limited
发表日期
2012-09-10
DOI
10.1155/2012/564741
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oncogenic KRAS Impairs EGFR Antibodies' Efficiency by C/EBPβ-Dependent Suppression of EGFR Expression
- (2015) Stefanie Derer et al. NEOPLASIA
- Trends in colorectal cancer incidence rates in New Zealand, 1981-2004
- (2012) Ankit B. Shah et al. ANZ JOURNAL OF SURGERY
- Trends in Colorectal Cancer Incidence Rates in the United States by Tumor Location and Stage, 1992-2008
- (2012) R. L. Siegel et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
- (2012) X. Liao et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive, and Therapeutic Implications
- (2012) F. A. Sinicrope et al. CLINICAL CANCER RESEARCH
- Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials
- (2012) Carsten Bokemeyer et al. EUROPEAN JOURNAL OF CANCER
- Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist’s initiative
- (2012) K. M. Landsbergen et al. Familial Cancer
- Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum
- (2012) Mai Yamauchi et al. GUT
- Aberrant protein expression and frequent allelic loss of MSH3 in colorectal cancer with low-level microsatellite instability
- (2012) Jens Plaschke et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis
- (2012) J Verhulst et al. JOURNAL OF CLINICAL PATHOLOGY
- Correlation of tumour BRAF mutations andMLH1methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification
- (2012) Michael T Parsons et al. JOURNAL OF MEDICAL GENETICS
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
- (2012) Doron Lipson et al. NATURE MEDICINE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Significance and Molecular Associations of Tumor Growth Pattern in Colorectal Cancer
- (2011) Teppei Morikawa et al. ANNALS OF SURGICAL ONCOLOGY
- Tumour heterogeneity and drug resistance: Personalising cancer medicine through functional genomics
- (2011) Alvin J.X. Lee et al. BIOCHEMICAL PHARMACOLOGY
- Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes
- (2011) Kari Hemminki et al. BMC CANCER
- The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy
- (2011) Byung-Hoon Min et al. BMC CANCER
- Trends in colorectal cancer incidence: a period and birth-cohort analysis in a well-defined French population
- (2011) Marion Chauvenet et al. BMC CANCER
- Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours
- (2011) Y Pan et al. BRITISH JOURNAL OF CANCER
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
- (2011) T Yokota et al. BRITISH JOURNAL OF CANCER
- Association between deficient mismatch repair system and efficacy to irinotecan-containing chemotherapy in metastatic colon cancer
- (2011) Jeong Eun Kim et al. CANCER SCIENCE
- Targeted therapies for advanced non-small-cell lung cancer: Current status and future implications
- (2011) Ana Custodio et al. CANCER TREATMENT REVIEWS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Molecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single Institution
- (2011) B. E. Sylvester et al. CLINICAL CANCER RESEARCH
- Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
- (2011) S. Ogino et al. CLINICAL CANCER RESEARCH
- Is There a Role for IGF1R and c-MET Pathways in Resistance to Cetuximab in Metastatic Colorectal Cancer?
- (2011) Alessandro Inno et al. Clinical Colorectal Cancer
- Integration of Biologic Agents With Cytotoxic Chemotherapy in Metastatic Colorectal Cancer
- (2011) Vikram K. Jain et al. Clinical Colorectal Cancer
- Recent Developments in Treatment Stratification for Metastatic Breast Cancer
- (2011) Sarah Barton et al. DRUGS
- The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer
- (2011) Sung Pil Hong et al. EUROPEAN JOURNAL OF CANCER
- Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer
- (2011) Cecily P. Vaughn et al. GENES CHROMOSOMES & CANCER
- High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis
- (2011) V. W.-S. Wong et al. GUT
- Oncogenic PIK3CA mutations in colorectal cancers and polyps
- (2011) Vicki L.J. Whitehall et al. INTERNATIONAL JOURNAL OF CANCER
- Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy
- (2011) Satu Oltedal et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Impact ofKRASandBRAFGene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer
- (2011) Timothy J. Price et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
- (2011) Leena Gandhi et al. JOURNAL OF CLINICAL ONCOLOGY
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Mortality by Stage for Right- Versus Left-Sided Colon Cancer: Analysis of Surveillance, Epidemiology, and End Results–Medicare Data
- (2011) Jennifer M. Weiss et al. JOURNAL OF CLINICAL ONCOLOGY
- KRAS, NRAS, PIK3CA Exon 20, and BRAF Genotypes in Synchronous and Metachronous Primary Colorectal Cancers
- (2011) Katharina Balschun et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Peritoneal carcinomatosis of colon cancer origin: Highest incidence in women and in patients with right-sided tumors
- (2011) Ole Helmer Sjo et al. JOURNAL OF SURGICAL ONCOLOGY
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
- (2011) F. A. Sinicrope et al. JNCI-Journal of the National Cancer Institute
- Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
- (2011) Timothy S Maughan et al. LANCET
- Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
- (2011) Willem van Gijn et al. LANCET ONCOLOGY
- Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma
- (2011) Brian T. Hill et al. LEUKEMIA & LYMPHOMA
- PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors
- (2011) F. Janku et al. MOLECULAR CANCER THERAPEUTICS
- The Role of HER-3 Expression in the Prediction of Clinical Outcome for Advanced Colorectal Cancer Patients Receiving Irinotecan and Cetuximab
- (2011) M. Scartozzi et al. ONCOLOGIST
- The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
- (2011) Elizabeth O Lillie et al. Personalized Medicine
- PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers
- (2011) Filip Janku et al. PLoS One
- Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009
- (2010) R. Adam et al. ANNALS OF ONCOLOGY
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Targeted therapy in advanced colorectal cancer: more data, more questions
- (2010) Sebastian L. Ochenduszko et al. ANTI-CANCER DRUGS
- Mutations in TGFbeta-RII and BAXmediate tumor progression in the later stages of colorectal cancer with microsatellite instability
- (2010) Masakazu Yashiro et al. BMC CANCER
- Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin
- (2010) Manuela Pinheiro et al. BMC CANCER
- NRAS Mutations Are Rare in Colorectal Cancer
- (2010) Natsumi Irahara et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- 5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer
- (2010) Rodrigo Jover et al. GASTROENTEROLOGY
- Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field
- (2010) S. Ogino et al. GUT
- Selecting Systemic Cancer Therapy One Patient at a Time: Is There a Role for Molecular Profiling of Individual Patients With Advanced Solid Tumors?
- (2010) James H. Doroshow JOURNAL OF CLINICAL ONCOLOGY
- Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial
- (2010) Alicia F.C. Okines et al. JOURNAL OF CLINICAL ONCOLOGY
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
- (2010) Jean-Yves Douillard et al. JOURNAL OF CLINICAL ONCOLOGY
- Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers
- (2010) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients
- (2010) Inti Zlobec WORLD JOURNAL OF GASTROENTEROLOGY
- Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience
- (2009) R A Adams et al. BRITISH JOURNAL OF CANCER
- Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy
- (2009) V Catalano et al. BRITISH JOURNAL OF CANCER
- Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy
- (2009) Seung Tae Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells
- (2009) Hideaki Karasawa et al. CANCER SCIENCE
- Trends in colorectal cancer incidence in Norway 1962â2006: an interpretation of the temporal patterns by anatomic subsite
- (2009) Inger Kristin Larsen et al. INTERNATIONAL JOURNAL OF CANCER
- Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
- (2009) Monica M. Bertagnolli et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
- (2009) Pierre Laurent-Puig et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial
- (2009) Phil Quirke et al. LANCET
- The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer
- (2009) Seung Tae Kim et al. MEDICAL ONCOLOGY
- More is less—combining targeted therapies in metastatic colorectal cancer
- (2009) Cornelis J. A. Punt et al. Nature Reviews Clinical Oncology
- Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer
- (2008) A. J. French et al. CLINICAL CANCER RESEARCH
- Wild-TypeBRAFIs Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
- (2008) Federica Di Nicolantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
- (2008) Rafael G. Amado et al. JOURNAL OF CLINICAL ONCOLOGY
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
- (2008) Andrew G Renehan et al. LANCET
- Detection of Mutations inEGFRin Circulating Lung-Cancer Cells
- (2008) Shyamala Maheswaran et al. NEW ENGLAND JOURNAL OF MEDICINE
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selected Combination Therapy with Sorafenib: A Review of Clinical Data and Perspectives in Advanced Solid Tumors
- (2008) L. Dal Lago et al. ONCOLOGIST
- Significance of Bcl-xL in human colon carcinoma
- (2008) You-Li Zhang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Endpoints and other considerations in phase I studies of targeted anticancer therapy: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT)
- (2007) Christopher M. Booth et al. EUROPEAN JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started